Graves Mark 4
4 · MIMEDX GROUP, INC. · Filed May 10, 2022
Insider Transaction Report
Form 4
Graves Mark
SVP & Chief Compliance Officer
Transactions
- Sale
Common Stock
2022-05-09$3.50/sh−3,891$13,622→ 133,608 total
Footnotes (2)
- [F1]The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.
- [F2]The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $3.50 to $3.51, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.